Compare Charles River Laboratories Intl. Inc (CRL) vs Kyndryl Holdings Inc (KD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Kyndryl Holdings Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $302.17 (market cap $14.23B), while Kyndryl Holdings Inc trades at $11.81 (market cap $2.59B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 5.5× Kyndryl Holdings Inc's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Kyndryl Holdings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Kyndryl Holdings Inc for 36 Days on average.
| CRL | KD | |
|---|---|---|
Market Cap | $14.23B | $2.59B |
Volume | 1,176,885 | 5,354,348 |
Sector | Health | Technology |
52-Week High | $310.77 | $29.76 |
52-Week Low | $149.93 | $10.59 |
Typical Hold Time | 33 Days | 36 Days |
Enterprise Value | $17.06B | $5.41B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $300.53, up 0.08% on the day, with a bullish technical outlook and strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, though it faces profitability challenges with a negative net income margin and ROE. Recent investor day presentations highlighted a strategic plan targeting 5-7% revenue growth and $300 million in savings by 2030, driving positive sentiment.
The outlook is cautiously optimistic, supported by analyst buy ratings and a $305.50 consensus price target, but risks include ongoing margin pressure, volatile non-human primate costs, and a high valuation multiple. Earnings growth and successful execution of the new strategic plan are critical for sustained upside.
Kyndryl (KD) trades at $11.45, down 0.26% on the day, reflecting a challenging technical and fundamental environment. The stock exhibits a bearish technical signal with key support at $11 and resistance at $12, while recent earnings misses in Q4 2025 and Q1 2026 contrast with a beat in Q2 2026. Despite a low P/S ratio of 0.18 and positive net income of $252 million in 2025, the company's revenue has declined from $18.3B in 2022 to $15.1B in 2025. Recent news highlights a strategic focus on AI, including the launch of an innovation lab and the acquisition of Healthcare IT Leaders.
The outlook for KD is mixed, with a consensus price target of $14.67 suggesting potential upside, but analyst sentiment is cautious with 71% hold ratings. Key opportunities include AI-driven growth and improving profitability, while risks involve persistent revenue declines, high debt levels, and competitive pressures in the IT services sector. Execution on AI initiatives and future earnings performance will be critical for stock appreciation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Kyndryl Holdings Inc
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.
Read more on KD →
